2001年清华大学物理系研究生毕业后，长期从事网络安全和信息化领域的工作。

YINGBO LIN, PH.D Dept. of Oncology and Pathology, Cancer Centrum Karolinska, Karolinska Hospital, Sweden E-mail: linyingbo@gmail.com; Yingbo.Lin@ki.se, Tel: +46(0)700226288; +86 14753583427 Dr. Yingbo Lin has 15 years experience from academic and scientific research in China and the Nordics, where he has specialised in cancer studies. He has conducted research at Ocean University Qingdao, Uppsala University and Karolinska Institute. Alongside his research, Yingbo has worked as an adviser for Chinese Science Parks and Government Agencies in the Nordics. Working with communication on Chinese industrial policies, policy support and regulations for newly established foreign businesses in China. This combined with his experience from Chinese and Nordic research institutes; Yingbo has developed an expertise in regulatory systems and policies for foreign innovation projects and cooperation in China. CURRENT POSITIONS Assistant Professor | Department of Oncology-Pathology, Karolinska Institute Founder and CEO | Sinorvodic Investment and Consulting AB Executive President | Nordic Chinese Association for Innovation and Entrepreneurship General Manager | Suzhou Centre for International Innovation and Entrepreneurship in Sweden Senior Advisor | Shenzhen China-Europe Innovation Centre EDUCATION • 2004.9-2009.7 Ph.D at Lab of Pathology and Immunology of Aquatic Animals, Dept. of Aquaculture, Fisheries College, Ocean University of China, China. • 2008.1-2009.3 Joint Ph.D candidate at Cancer Centre Karolinska, Karolinska Institute, Sweden. • 2007.9-2007.11 Guest researcher at Evolutionary Biology Centre, Uppsala University, Sweden. • 2000.9-2003.7 Bachelor Degree in Biology Science at Dept. of Biology, Biology College, Ocean University of China, China. ACADEMIC OUTPUTS Lin Y, Seger N, Chen Y, Hesla A, Wejde J, Ghaderi M, Tsagkozis P, Larsson O, Haglund F. hTERT promoter mutations in chondrosarcomas associate with progression and disease-related mortality, Modern Pathology, 2018 31: 1834–1841. Lin Y, van Duyvenvoorde HA, Liu H, Yang C, Warsito D, Yin C, Kant SG, Haglund F, Wit JM, Larsson O. Characterization of an activating R1353H insulin-like growth factor 1 receptor variant in a male with extreme tall height. Eur J Endocrinol. 2018 Aug;179(2):85-95. doi: 10.1530/EJE-18-0176. Epub 2018 May 22. Lin Y, Seger N, Tsagkozis P, Hesla AC, Ghaderi M, Chen Y, Ehnman M, Warsito D, Wejde J, Larsson O, Haglund F. Telomerase promoter mutations and copy number alterations in solitary fibrous tumours. J Clin Pathol. 2018 Apr 27. pii: jclinpath-2018-205132. doi: 10.1136/jclinpath-2018-205132. Lin Y (Corresponding Author), Liu H, Waraky A, Haglund F, Agarwal P, Jernberg-Wiklund H, Warsito D, Larsson O. SUMO-modified insulin-like growth factor 1 receptor (IGF-1R) increases cell cycle progression and cell proliferation. Journal of Cellular Physiology. 2017: DOI:10.1002/jcp.25818 Xie B, He X, Guo G, Zhang X, Li J, Liu J, Lin Y (Corresponding Author). High-throughput screening identified mitoxantrone to induce death of hepatocellular carcinoma cells with autophagy involvement. Biochem Biophys Res Commun. 2020 Jan 1;521(1):232-237. doi: 10.1016/j.bbrc.2019.10.114. Packham S, Lin Y (Co-first author), Zhao Z, Warsito D, Rutishauser D, Larsson O. The Nucleus-Localized Epidermal Growth Factor Receptor Is SUMOylated. Biochemistry. 2015 Aug 25;54(33):5157-66. Trocmé E, Mougiakakos D, Johansson CC, All-Eriksson C, Economou MA, Larsson O, Seregard S, Kiessling R, Lin Y (Corresponding Author). Nuclear HER3 is associated with favorable overall survival in uveal melanoma. Int J Cancer. 2012 Mar 1;130(5):1120-7. Lin Y, Zhan W, Li Q, Zhang Z, Wei X, Sheng X. Ontogenesis of haemocytes in shrimp (Fenneropenaeus chinensis) studied with probes of monoclonal antibody. Dev Comp Immunol. 2007;31(11):1073-81. Waraky A, Lin Y, Warsito D, Haglund F, Aleem E, Larsson O. Nuclear insulin-like growth factor 1 receptor phosphorylates proliferating cell nuclear antigen and rescues stalled replication forks after DNA damage. J Biol Chem. 2017 Nov 3;292(44):18227-18239. doi: 10.1074/jbc.M117.781492. Epub 2017 Sep 18. Zhao Z, Wang S, Lin Y, Miao Y, Zeng Y, Nie Y, Guo P, Jiang G, Wu J. Epithelial-mesenchymal transition in cancer: Role of the IL-8/IL-8R axis. Oncol Lett. 2017 Jun;13(6):4577-4584. doi: 10.3892/ol.2017.6034. Epub 2017 Apr 13. Warsito D, Lin Y, Gnirck AC, Sehat B, Larsson O. Nuclearly translocated insulin-like growth factor 1 receptor phosphorylates histone H3 at tyrosine 41 and induces SNAI2 expression via Brg1 chromatin remodeling protein. Oncotarget. 2016 Jul 5;7(27):42288-42302. Strömberg T, Feng X, Delforoush M, Berglund M, Lin Y, Axelson M, Larsson O, Georgii-Hemming P, Lennartsson J, Enblad G. Picropodophyllin inhibits proliferation and survival of diffuse large B-cell lymphoma cells. Med Oncol. 2015 Jul;32(7):188. Packham S, Warsito D, Lin Y, Sadi S, Karlsson R, Sehat B, Larsson O. Nuclear translocation of IGF-1R via p150(Glued) and an importin-β/RanBP2-dependent pathway in cancer cells. Oncogene. 2015 Apr 23;34(17):2227-38. Ibarra C, Vicencio JM, Estrada M, Lin Y, Rocco P, Rebellato P, Munoz JP, Garcia-Prieto J, Quest AF, Chiong M, Davidson SM, Bulatovic I, Grinnemo KH, Larsson O, Szabadkai G, Uhlén P, Jaimovich E, Lavandero S. Local control of nuclear calcium signaling in cardiac myocytes by perinuclear microdomains of sarcolemmal insulin-like growth factor 1 receptors. Circ Res. 2013 Jan 18;112(2):236-45. Feng X, Aleem E, Lin Y, Axelson M, Larsson O, Strömberg T. Multiple antitumor effects of picropodophyllin in colon carcinoma cell lines: clinical implications. Int J Oncol. 2012 Apr;40(4):1251-8. Deng H, Lin Y, Badin M, Vasilcanu D, Strömberg T, Jernberg-Wiklund H, Sehat B, Larsson O. Over-accumulation of nuclear IGF-1 receptor in tumor cells requires elevated expression of the receptor and the SUMO-conjugating enzyme Ubc9. Biochem Biophys Res Commun. 2011 Jan 14;404(2):667-71. Sehat B, Tofigh A, Lin Y, Trocmé E, Liljedahl U, Lagergren J, Larsson O. SUMOylation mediates the nuclear translocation and signaling of the IGF-1 receptor. Sci Signal. 2010 Feb 9;3(108):ra10. RESEARCH SUPPERVISONAS • Co-supervisor of two Ph.D student: Dudi Warsito (2009-2014), Sylvia Packham (2010-2015) and Yi Chen (2018 till now) ACCOMPLISHED SOCIAL RPROJECTS 2019, “Win-the-Future” Venture Contest (Sweden Division), head of the organization committee 2019, the 2nd China-Europe Innovation Cooperation Summit & Technology Start-up Forum, member of the organization committee 2019, China (Shenzhen) Innovation & Entrepreneurship International Competition (IEIC) Sweden Division, member of the organization committee 2018, the 10th “Win in Suzhou” Venture Contest (Sweden Division), head of the organization committee. 2018, the 1st China-Europe Innovation Cooperation Summit & Technology Start-up Forum, member of the organization committee.

张先生拥有丰富的投资及投行工作经验，负责天亿资本期间，曾经完成：航天科工收购尤夫股份，东旭光电收购申龙客车，东方精工收购普莱德，翰宇药业收购成纪药业、英国利洁时(Reckitt Benckiser)并购桂龙药业；国润天能新能源科技公司、吉丰农机、金丝猴集团、安徽应流集团的私募股权投资、中国天瑞控股私募及上市、河南蓝信科技、亿品传媒私募、蓝山屯河化工集团的私募股权投资、以及华盛顿邮报收购雅思教育等项目。 在工银国际工作七年，获得忠诚服务奖。曾经负责三九医药集团的并购和重组、华源医药集团并购和重组、德隆集团旗下五家上市公司的并购和债务重组、聚友集团、广东风华高科集团的债务重组； 在海外上市方面，完成过工商银行，中国人寿、北泰汽车、比亚迪电池、东瑞制药等公司上市的工作。在私募融资方面也有丰富的经验，曾经完成河北港陆钢铁、北京华麟汽车等项目的私募等项目；基础设施的并购如青岛城市燃气的并购和芜湖电厂三期的收购工作。

尹航，男，高级电力电子专家，德国创新与技术研究院院长，德国中国研发创新联盟秘书长，德国柏林工业大学电力电子工学博士，曾任国家电网公司全球能源互联欧洲研究院高级项目经理，先进能源技术部门主任助理。 自2014年6月欧洲院成立起，他加入欧洲院担任研究助理。 2017年10月，他担任跨区域多台虚拟同步发电机运行控制及电网支持设备关键技术研究项目经理，负责项目整体技术方向及大功率并网策略研究。在欧洲院工作5年期间，参与和负责国家级项目1项，适用于分布式可再生能源交直流互联的关键设备研制；欧盟项目2项，包括中德E-Bus电动汽车标准项目，中丹基于碳化硅电力电子器件的高效率，高可靠性研究；国家电网科技项目3项，包括虚拟同步机、海上平台设计及特高压换流阀智能传感器项目；国际咨询项目1项，江苏苏州同里新能源小镇综合能源规划国际咨询项目。在柏林工大攻读博士期间，主要针对并网逆变器控制策略研究。设计了5兆瓦风机电气主体部分，包括变换器，直流侧电容，网测滤波器。为了研究和验证并网策略，设计并搭建了一个10千伏安低压背靠背三电平试验台。通过分析比较，提出一种多步长模型预测控制，可以降低开关频率，提升系统效率0.14%。在国内硕士期间，设计了基于DSP2407控制稀土永磁电机矢量控制的单轴稳定平台，用于某型号火箭弹惯导及计算机工作稳定平台。经实际发射实验，稳定平台抗干扰能力强，控制精度高，成功列为兵器装备型号。曾在国际学术杂志和学术会议上发表论文13篇，申请专利9项，发表著作1部。2020年6月，担任德国创新与技术研究院院长，依托德国中国研发创新联盟平台，开展中德科技创新合作。 Mr. Dr. -Ing. Yin, Hang, senior power electronics expert, CEO and founder of the GIT - German Institute of Innovation and Technology GmbH (GIT), Secretary-General of the German-Chinese R&D Innovation Alliance, PhD in Power Electronics Engineering at the Technical University of Berlin, Germany, formerly senior project manager of the State Grid Corporation of China, Global Energy Interconnection Research Institute GmbH (GEIRI), Director of Innovative Energy Technology Department. Since the establishment of the GEIRI in June 2014, he joined the GEIRI Europe as a research assistant. In October 2017, he served as the project manager of the key technology research on the operation control of multiple virtual synchronous generators across the region and the grid support equipment, responsible for the overall technical direction of the project and the research on the high-power grid-connected strategy. During the 6 years of working at GEIRI, he participated in and was responsible for 1 national-level project, which is development of key equipment for distributed renewable energy AC/DC interconnection; 2 EU projects, including the Sino-German E-Bus electric vehicle standard project, Sino-Denmark Research on high efficiency and high reliability based on silicon carbide power electronic devices; 3 State Grid science and technology projects, including virtual synchronous machine, offshore platform design and UHV converter valve intelligent sensor project; 1 international consulting project, Tongli, Suzhou, Jiangsu International consulting project for comprehensive energy planning of new energy towns. During my PhD study at Berlin University of Technology, Dr. Yin focused on the research of grid-connected inverter control strategy. The electrical main part of a 5 MW wind turbine was designed, including the converter, DC side capacitor, and network test filter. In order to study and verify the grid connection strategy, a 10 kVA low-voltage back-to-back three-level test bed was designed and built. Through analysis and comparison, a multi-step model predictive control is proposed, which can reduce the switching frequency and increase the system efficiency by 0.14%. During the domestic master's degree, he designed a single-axis stable platform based on DSP2407 to control rare earth permanent magnet motor vector control, which is used for a certain type of rocket inertial navigation and computer stable platform. Through actual launch experiments, the stable platform has strong anti-interference ability and high control accuracy. He has published 13 papers in international academic journals and academic conferences, applied for 9 patents, and published 1 book. From June 2020, he served as the CEO of GIT, relying on the German-Chinese R&D Innovation Alliance platform to carry out Sino-German scientific and technological innovation cooperation.